Michael A. Sherman's most recent trade in Werewolf Therapeutics Inc was a trade of 27,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics Inc | Michael A. Sherman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 1,150,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 875,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 700,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 632,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 557,050 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 233,413 | 0 (0%) | 0% | 8.5 | 1,995,681 | Common Stock |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 102,995 | 0 (0%) | 0% | 8.5 | 880,607 | Common Stock |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 8.55 per share. | 21 Apr 2025 | 87,000 | 0 (0%) | 0% | 8.6 | 743,850 | Common Stock |
| Chimerix Inc | Michael A. Sherman | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Apr 2025 | 60,000 | 0 | - | - | Employee Stock Option (Right to Buy) |